Deutsche Bank AG Invests $446.26 Million in Danaher Corporation $DHR

Deutsche Bank AG purchased a new stake in Danaher Corporation (NYSE:DHR) in the second quarter, HoldingsChannel.com reports. The institutional investor purchased 2,342,847 shares of the conglomerate’s stock, valued at approximately $446,265,000.

Other institutional investors also recently modified their holdings of the company. Northwestern Mutual Wealth Management Co. increased its holdings in shares of Danaher by 303.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 248,020 shares of the conglomerate’s stock valued at $56,777,000 after purchasing an additional 186,584 shares during the last quarter. Legal & General Group Plc raised its position in shares of Danaher by 1.0% in the fourth quarter. Legal & General Group Plc now owns 4,495,287 shares of the conglomerate’s stock valued at $1,029,061,000 after buying an additional 43,169 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Danaher by 51.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 271,734 shares of the conglomerate’s stock valued at $62,205,000 after acquiring an additional 92,323 shares during the period. Advisors Capital Management LLC increased its holdings in Danaher by 14.0% in the 4th quarter. Advisors Capital Management LLC now owns 54,845 shares of the conglomerate’s stock valued at $12,555,000 after buying an additional 6,720 shares during the period. Finally, Handelsbanken Fonder AB increased its stake in Danaher by 10.9% in the second quarter. Handelsbanken Fonder AB now owns 289,223 shares of the conglomerate’s stock valued at $55,091,000 after acquiring an additional 28,425 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Performance

Shares of Danaher stock opened at $202.44 on Tuesday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The business has a 50 day moving average price of $193.52 and a 200-day moving average price of $192.67. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a market cap of $142.31 billion, a PE ratio of 35.96, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. During the same period in the previous year, the firm earned $0.77 EPS. The business’s revenue for the quarter was up 5.5% compared to the same quarter last year. Equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the company. Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a report on Monday, July 6th. UBS Group lowered their price target on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. HSBC lowered their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.